CDX2 and adenocarcinoma: CDX2 positivity was noted in all adenocarcinomas, while P63 positivity was noted in all squamous cell carcinomas and focally positive in adenocarcinomas with squamous differentiation (Figure 14, Figure 15, Figure 16, Figure 17, Figure 18 and Figure 19).